302 related articles for article (PubMed ID: 8393668)
1. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
[TBL] [Abstract][Full Text] [Related]
2. FS2. a mamba venom toxin, is a specific blocker of the L-type calcium channels.
Yasuda O; Morimoto S; Jiang B; Kuroda H; Kimura T; Sakakibara S; Fukuo K; Chen S; Tamatani M; Ogihara T
Artery; 1994; 21(5):287-302. PubMed ID: 8826098
[TBL] [Abstract][Full Text] [Related]
3. Neuropharmacological characterization of voltage-sensitive calcium channels: possible existence of neomycin-sensitive, omega-conotoxin GVIA- and dihydropyridines-resistant calcium channels in the rat brain.
Yamada K; Teraoka T; Morita S; Hasegawa T; Nabeshima T
Jpn J Pharmacol; 1993 Dec; 63(4):423-32. PubMed ID: 8121077
[TBL] [Abstract][Full Text] [Related]
4. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals.
Xu YF; Hewett SJ; Atchison WD
J Neurophysiol; 1998 Sep; 80(3):1056-69. PubMed ID: 9744921
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
7. Identification of omega-conotoxin binding sites on adrenal medullary membranes: possibility of multiple calcium channels in chromaffin cells.
Jan CR; Titeler M; Schneider AS
J Neurochem; 1990 Jan; 54(1):355-8. PubMed ID: 2152797
[TBL] [Abstract][Full Text] [Related]
8. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
Dobrev D; Milde AS; Andreas K; Ravens U
Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
[TBL] [Abstract][Full Text] [Related]
9. Separate binding and functional sites for omega-conotoxin and nitrendipine suggest two types of calcium channels in bovine chromaffin cells.
Ballesta JJ; Palmero M; Hidalgo MJ; Gutierrez LM; Reig JA; Viniegra S; Garcia AG
J Neurochem; 1989 Oct; 53(4):1050-6. PubMed ID: 2549193
[TBL] [Abstract][Full Text] [Related]
10. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
Homaidan FR; Donowitz M; Weiland GA; Sharp GW
Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of omega-conotoxin GVI A and MVIIC binding to Cav 2.1 and Cav 2.2 channels captured by anti-Ca2+ channel peptide antibodies.
Ichida S; Abe J; Komoike K; Imanishi T; Wada T; Masuko T; Minami T
Neurochem Res; 2005 Apr; 30(4):457-66. PubMed ID: 16076016
[TBL] [Abstract][Full Text] [Related]
12. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
13. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
14. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
Murphy BJ; Washkurak AW; Tuana BS
Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
[TBL] [Abstract][Full Text] [Related]
16. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels.
Kanda S; Adachi-Akahane S; Nagao T
Eur J Pharmacol; 1998 Oct; 358(3):277-87. PubMed ID: 9822895
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels.
Kristipati R; Nádasdi L; Tarczy-Hornoch K; Lau K; Miljanich GP; Ramachandran J; Bell JR
Mol Cell Neurosci; 1994 Jun; 5(3):219-28. PubMed ID: 8087420
[TBL] [Abstract][Full Text] [Related]
19. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
20. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
Miwa K; Miyagi Y; Araie E; Sasayama S
Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
